Effect of renin–angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy

BACKGROUND: Cancer treatment with vascular endothelial growth factor signalling pathway (VSP) inhibitors frequently causes hypertension. Although previous reports suggested that the antihypertensive drug renin–angiotensin system inhibitor (RASI) may have a positive synergistic effect with VSP inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriyama, Shohei, Hieda, Michinari, Kisanuki, Megumi, Kawano, Shotaro, Yokoyama, Taku, Fukata, Mitsuhiro, Kusaba, Hitoshi, Maruyama, Toru, Baba, Eishi, Akashi, Koichi, Fukuda, Haruhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Aortic and Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743396/
https://www.ncbi.nlm.nih.gov/pubmed/36600585
http://dx.doi.org/10.1136/openhrt-2022-002135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743396/
https://www.ncbi.nlm.nih.gov/pubmed/36600585
http://dx.doi.org/10.1136/openhrt-2022-002135

Ejemplares similares